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INTRODUCTION
Drugs have varying potential to induce nausea and/or vomiting. Center for vomiting in medulla oblongata is under the influence of substances from blood, stimulation of nerve endings in gastrointestinal tract and impulses from chemioreceptor zone. Neurotransmitters with significant effect on the center are histamine, acetylcholine, dopamine, 5-hydroxytriptamine, substance P and endogenous cannabinoids (1). Cytostatic drugs cause nausea in as much as 10% (drugs with low emetogenic potential) to 90% (drugs with high emetogenic potential) patients (2) , while opioids cause nausea in 48% of patients when used for treatment of cancer pain and in 27% when used for postoperative pain (3) . Rate of nausea after oral administration of iron salts amounts to 11% (4) , and it is probably caused by accumulation of free radicals in gastrointestinal mucosa (5) .Drug-induced nausea is big problem in everyday clinical practice, as many patients are not compliant to the prescribed therapy or discontinue the therapy due to nausea.
There are several questionnaires for measurement of intensity of nausea after drug administration, usually developed specifically for certan drug groups, like ChemotherapyInduced Nausea and Emesis Quality of Life questionnaire (CINI QOL) (6) or the Gastrointestinal Symptom Questionnaire (GSQ)designed to measure nausea after oral drug intake (7) and tested in patients taking iron salts. Within its program of developing standardized set of patient-reported outcomes (Patient-Reported Outcomes Measurment Information -PROMIS) National Institute of Health in USA created also Gastrointestinal Symptom Scales (GSS), and one of them is measuring nausea caused by either disease or drug (8) . However, these scales are either too settings specific (like CINI QOL) or were not properly tested for reliability and validity after drug administration (like GSQ or PROMIS GSS-nausea). Reliable and valid questionnaire for measurement of drug-induced nausea as general phenomenon could be important clinical tool for assesing tolerability of emetogenic drugs and necessity to discontinue therapy or switch to less emetogenic one.If drug-induced nausea is mild, a prescriber could further decrease it through timing intake of the drug with food or giving only one daily dose before going to bed, and in this way preserve potentially very efficient drug for the patient instead of switching to other drugs (which could cause nausea, too). Besides, after adequate explanation and rating of nausea, the patients with mild form will be more compliant to the prescribed therapy.
The aim of our study was to develop questionnaire for measurement of intensity of drug-induced nausea, and test its reliability and validity on a sample of adult patients taking iron salts orally.
MATERIALS AND METHODS

Design
The study was of a cross-sectional type, and assessed reliability and validity of newly developed questionnaire for measurement of drug-induced nausea (Drug-Induced Nausea Scale -DINS) among outpatients taking iron salts orally.
Construction of the new questionnaire
Developing of the new questionnaire was done according to the guidelines set by Robert F. DeVellis(9), through eight steps. In the first step (determining object of measurement) drug-induced nausea was chosen as an object of measurement, being one of the most frequent causes of discontinuation of effective drug therapy (10) . The second step, generating an item pool, was conducted through two brainstorming sessions of the authors, one week apart. In the third step (determining format for measurement) each item was constructed in the form of positive statement which should reflect certain element of nausea.Five possible answers were offered for each statement, in the form of Likert's scale:
"never", "rarely", "sometimes", "often", and "always". The answers were rated from 1 ("never") to 5 ("always").Total score of the questionnaire was calculated by summation of answers to individual items. The patients with the total score from 1 to 10 had mild nausea, those from 11 to 20 moderate nausea, and the patients with the score from 21 to 25 severe nausea. The fourth step (revision and correction of the initial pool of items) was made by the three member expert committee composed of a psychiatrist, a gastroenterologist and a 
Data collection -population and the sample
Final Serbian versions of the both new (DINS) and translated (PROMIS-GSSnausea) questionnaires were tested for reliability on outpatients who visited community pharmacies in Osečina, western Serbia. The visits took place during the year 2016. The inclusion criteria were oral intake of iron salts for at least two weeks, literacy, and age over 18. The exclusion criteria were previous gastrectomy, cognitive disorders (score at MiniMental State Examination below 24), mood disorders and mental retardation. The sample of the patients was of consecutive nature, i.e. all patients who visited community pharmaciesduring the study period (and satisfied inclusion and exclusion criteria) were offered the questionnaire. During the first encounter the questionnaires were completed in two ways: at first, by the investigators who were questioning the patients, and second, by the patients themselves. At the second encounter, two weeks later, the patients were repeatedly interviewed by the study investigators who completed the same questionnaires again.The study was approved by the Ethics Committee of Clinical Center Kragujevac, Serbia. The patients were treated with due respect and care, according to the principles stated in Declaration of Helsinki.
Data analysis
Reliability testing
Reliability of the questionnaire was tested by three methods. First, internal consistency was determined through calculation of Cronbach's alpha for the questionnaire as a whole. Second, the questionnaire was divided by split-half method to two parts with the same number of questions, and Cronbach's alpha for each of the parts was calculated.
Using the alphas for both parts, number of questions in each part and average correlation between questions in both parts of the original questionnaire, the Spearman-Brown coefficient for the questionnaire as a whole was calculated by the Spearman-Brown "prediction" formula (12) . Third, for each question mean score and their variances were calculated, in order to check their suitability for measurement of whole extent of nausea severity.
Factorial analysis
Principal component analysis of the questionnaire was made in order to discover principal factors (13) .Principal component analysis groups the items of a scale to a smaller number of principal components which describe most of the variance of the responses to the scale items. Each of the principal components identified covers part of the variance in the data, and they are not correlated between themselves. Components (factors)covering maximal variance are kept, while the otherswith small amount of variance are discarded.
The amount of variance covered by each component is measured by its eigenvalue. First, suitability of the questionnaire and sample for factorial analysis was tested by KaiserMeyer-Olkin measure of sampling adequacy and by the Bartlett's test of sphericity. Then, the factors were extracted at first without rotation, with conditions that Eigenvalues had to be greater than 1.0, and using Scree-plot (the extracted factors were above the "elbow" of the graph). Second, referent axes were rotated orthogonally, by the Varimax method, and another extraction of the factors was made, using the same criteria as for the unrotated solution. The following was reported for the extracted factors: loadings, eigenvalues, and percentage of variance explained. The extracted factors were than named accordingly. 
Temporal stability
Temporal stability of the DINS and the PROMIS-GSS-nausea results was tested by second completion of the questionnaires by the investigators who repeatedly interviewed the patients two weeks after the first encounter. The patients were invited to the second encounter by phone.
RESULTS
The first version of the DINS questionnaire contained 5 questions, which after the pilot and minor adjustments was tested on the sample of 128 outpatients: mean age 45.8 ± 13.5 years, male/female ratio 16/112 (12.5%/87.5%), education elementary school / high school / university = 26.6% / 51.6% / 21.6%, place of residence, urban/rural = 83/45 (64.8%/35.2%), andall patients except 2 (1.6%) were prescribed with oral iron for treatment of anemia. Thirty-eight patients (29.7%) were taking iron salts before a meal, 7 (5.5%) during a meal, 68 (53.1%) after a meal and remaining 15 (11.7%) did not take care about the timing of drug intake. Seventy patients (54.7%) were previously introduced with gastrointestinal adverse effects of iron preparations, and the remaining 58 patients (45.3%)
were not. Sixteen patients (12.5%) did have previous experience with nausea after oral drug intake, and the remaining 112 (87.5%) did not. Finally, 53 patients (41.4%) suffered from at least one chronic non-contagious disease, and 75 (58.6%) did not.
Mean score of the DINS was 8.6 ± 5.1 (range from 5 to 25). There were no significant differences in severity of nausea (the DINS score) according to the sex (females Table 1 . After division of the DINS questionnaire by the split-half method the Spearman-Brown coefficient for the questionnaire as a whole was calculated by the Spearman-Brown "prediction" formula, and its value was 0.834.
When the scale was rated by the patients themselves, Cronbach's alpha was 0.897.
Cronbach's alpha of the PROMIS-GSS-nausea questionnaire with 4 items was 0.739, when the scale was rated by the investigators. After division of thePROMIS-GSSnausea questionnaire by the split-half method the Spearman-Brown coefficient for the questionnaire as a whole was calculated by the Spearman-Brown "prediction" formula, and its value was 0.662. When the scale was rated by the patients themselves, Cronbach's alpha was 0.737.
Factorial analysis
Factorial analysis of DINS was made by the principal components method. The Kaiser-Meyer-Olkin measure of sampling adequacy was 0.815 and the Bartlett's test of sphericity was significant (p = 0.000). Only one factor was extracted, explaining in total 70.1% of variance, and with eigenvalue 3.503.
Factorial analysis of PROMIS-GSS-nausea questionnaire was made also by the principal components method. The Kaiser-Meyer-Olkin measure of sampling adequacy was 0.614 and the Bartlett's test of sphericity was significant (p = 0.000). Only one factor was extracted, explaining in total 56.22% of variance, and with eigenvalue 2.249.
Validity
Construct validity of the questionnaire was confirmed by the panel of experts, who also helped with slight re-phrasing of the questions. Divergent criterion validity was tested through non-parametric correlation between scores of the DINS scale (when it was rated by investigator and by patients themselves) and scores of the IU scale (when it was rated by investigator and by patients themselves).
Convergent criterion validity was tested through non-parametric correlation between scores of the DINS scale (when it was rated by investigator and by patients themselves), scores of the PROMIS-GSS-nausea scale (when it was rated by investigator and by patients themselves).Correlation coefficients between the DINS and IU scales and between PROMIS-GSS-nausea and IU scales were below 0.2 and statistically insignificant. Non-parametric correlation was chosen due to non-normal distribution of some of the scores. Spearman's correlation coefficients are shown in the Multi-trait, multi-method matrix (Table 2) .
Temporal stability
The DINS scale showed excellent temporal stability: when rating (by the investigator) was repeated on the same patients two weeks later, the correlation between the scores (Spearman's coefficient) was 0.965 (p < 0.001). Cronbach's alpha after the repeated rating was 0.901.
The PROMIS-GSS-nausea scale also showed excellent temporal stability: when rating (by the investigator) was repeated on the same patients two weeks later, the correlation between the scores (Spearman's coefficient) was 0.947 (p < 0.001). Cronbach's alpha after the repeated rating was 0.742.
DISCUSSION
Final version of the DINS scale with 5items showed excellent reliability, both when rated by the investigators, and by the patients themselves. It was temporally stable, and both divergent and convergent validity tests had very good results. Factorial analysis revealed only one factor, which means that whole scale is measuring only one phenomenon, intensity of nausea, as was originally intended. DINS scale was also more reliable than previously validated PROMIS-GSS-nausea scale.
Although PROMIS-GSS-nausea scale was used for measuring intensity of nausea in a variety of gastronitestinal diseases, showing high ability to discriminate between subtle changes in the nausea intensity (15), it was not previously used to measure drug-induced nausea. In our study it showed necessary level of reliability for this purpose, but DINS surpassed it by far with its high Cronbach's alpha around 0.9.
Since nausea and vomiting are particularly severe in patient receiving chemotherapy, it is not surprising that the largest number of instruments for measuring drug-induced vomiting was specificaly developed in this area. Recent systematic review found seven instruments for measuring chemotherapy-induced nausea, retching and vomiting (16). Majority of these instruments cover three key domains (nausea, vomiting and retching)and are prepared in several forms which are adjusted for three different phases of nausea-vomiting-retching phenomenon: anticipatory, acute and delayed. Our instrument DINS is focused on nausea domain, which is usually the only one present when patients take less emetogenic drugs other than cytostatics(17). Therefore, DINS should not be used for measurement of chemotherapy induced nausea, retching and vomiting, but for estimation of nausea caused by less emetogenic drugs prescribed to outpatients.
Although limited to measurement of nausea, items from the DINS instrument cover essential aspects of this phenomenon, which could be applied also to vomiting and retching: occurrence (item 2), duration (item 1) and severity (items 3,4 and 5)(17). The Gastrointestinal Symptom Questionnaire by Pereira et al (7) also covered these aspects of nausea, but the answers to questions had only three modalities, "mild", "moderate" and "severe", limiting discriminative power of the scale. Although in their study Pereira and associates did not measure internal consistency of their questionnaire, most likely it would not be too high, since the questionnaire relates only to condition of a patient on the day of rating, and misses chronicity as important aspect of drug-induced nausea. We also would like to point out that second question (During drug therapy, did you feel nausea aways in the same time during a day?) could be betterformulated in a way which would take into account timing of a drug intake during the day(e.g.During drug therapy, did you feel nausea always after its administration?) in order to capture causality between intake of a drug and emergence of nausea. However, this new formulation would have to be tested in a future study.
Main limitations of this study werenon-homogenous nature of the study sample, i.e. some of the patients had previous experience with nausea after oral drug intake, some did not, and female sex was largely predominant, due to higher incidence of iron-deficiency anemia. This non-homogeneity could be responsible for somewhat wider dispersion of patients' responses. Besides, the patients were taking only one drug (iron salts) which causes nausea, so the results could be drug type -specific, and may not apply to nausea caused by other drugs. Future studies with the same questionnaire should be conducted on several patient subgroups which are taking other emetogenic drugs in order to get complete insight into its functionality.
CONCLUSION
In conclusion, DINS is reliable and valid instrument for measuring intensity of drug-induced nausea. Identification of patients with high intensity of drug-induced nausea by this questionnaire willhelp prescribers to decide whether the therapy should be stopped or the patient switched to less emetogenic therapy. Table   2 .Multi-trait, multi-methodcorrelationmatrix (non-parametricSpearman's coefficients). 
